Fortress Biotech, Inc. (FBIO) stock
FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
$1.88−0.11 (-5.53%)
Close on Nov 13, 2026Market cap $69.14MP/E –Yield –
Fortress Biotech total assets
Total assets on the balance sheet at the end of each period.
Fortress Biotech's total assets was $280.22M at Sep 30, 2026. For fiscal 2025 it was $185.55M, up 28.7% from the year before. Over ten years it grew 4.6% a year on average. The highest annual figure on record is $396.50M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $185.55M | +28.7% |
| FY2024 | Dec 31, 2024 | $144.22M | -13.9% |
| FY2023 | Dec 31, 2023 | $167.53M | -43.1% |
| FY2022 | Dec 31, 2022 | $294.30M | -25.8% |
| FY2021 | Dec 31, 2021 | $396.50M | +18.9% |
| FY2020 | Dec 31, 2020 | $333.41M | +47.3% |
| FY2019 | Dec 31, 2019 | $226.42M | +60.6% |
| FY2018 | Dec 31, 2018 | $140.99M | -42.7% |
| FY2017 | Dec 31, 2017 | $245.95M | +44.1% |
| FY2016 | Dec 31, 2016 | $170.73M | +43.9% |
| FY2015 | Dec 31, 2015 | $118.61M | +32.8% |
| FY2014 | Dec 31, 2014 | $89.33M | -11.2% |
| FY2013 | Dec 31, 2013 | $100.58M | +145.4% |
| FY2012 | Dec 31, 2012 | $40.99M | +75.4% |
| FY2011 | Dec 31, 2011 | $23.38M | +56.5% |
| FY2010 | Dec 31, 2010 | $14.94M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $280.22M | +54.5% |
| Q2 FY2026 | Jun 30, 2026 | $316.72M | +98.1% |
| Q1 FY2026 | Mar 31, 2026 | $356.87M | +100.4% |
| Q4 FY2025 | Dec 31, 2025 | $185.55M | +28.7% |
| Q3 FY2025 | Sep 30, 2025 | $181.41M | +42.7% |
| Q2 FY2025 | Jun 30, 2025 | $159.90M | +9.8% |
| Q1 FY2025 | Mar 31, 2025 | $178.07M | +8.2% |
| Q4 FY2024 | Dec 31, 2024 | $144.22M | -13.9% |
| Q3 FY2024 | Sep 30, 2024 | $127.09M | -15.6% |
| Q2 FY2024 | Jun 30, 2024 | $145.69M | -19.4% |
| Q1 FY2024 | Mar 31, 2024 | $164.65M | -37.5% |
| Q4 FY2023 | Dec 31, 2023 | $167.53M | -43.1% |
| Q3 FY2023 | Sep 30, 2023 | $150.55M | -53.5% |
| Q2 FY2023 | Jun 30, 2023 | $180.72M | -50.3% |
| Q1 FY2023 | Mar 31, 2023 | $263.55M | -35.4% |
| Q4 FY2022 | Dec 31, 2022 | $294.30M | -25.8% |
| Q3 FY2022 | Sep 30, 2022 | $323.56M | -20.7% |
| Q2 FY2022 | Jun 30, 2022 | $363.96M | -13.0% |
| Q1 FY2022 | Mar 31, 2022 | $407.93M | +4.3% |
| Q4 FY2021 | Dec 31, 2021 | $396.50M | +18.9% |
| Q3 FY2021 | Sep 30, 2021 | $407.83M | +37.8% |
| Q2 FY2021 | Jun 30, 2021 | $418.16M | +55.7% |
| Q1 FY2021 | Mar 31, 2021 | $391.04M | +70.9% |
| Q4 FY2020 | Dec 31, 2020 | $333.41M | +47.3% |
| Q3 FY2020 | Sep 30, 2020 | $295.88M | +33.5% |
| Q2 FY2020 | Jun 30, 2020 | $268.57M | +18.2% |
| Q1 FY2020 | Mar 31, 2020 | $228.76M | +14.1% |
| Q4 FY2019 | Dec 31, 2019 | $226.42M | +60.6% |
| Q3 FY2019 | Sep 30, 2019 | $221.59M | -1.5% |
| Q2 FY2019 | Jun 30, 2019 | $227.26M | -4.1% |
| Q1 FY2019 | Mar 31, 2019 | $200.54M | -24.3% |
| Q4 FY2018 | Dec 31, 2018 | $140.99M | -42.7% |
| Q3 FY2018 | Sep 30, 2018 | $224.92M | -8.2% |
| Q2 FY2018 | Jun 30, 2018 | $236.87M | -5.2% |
| Q1 FY2018 | Mar 31, 2018 | $265.08M | +25.1% |
| Q4 FY2017 | Dec 31, 2017 | $245.95M | +44.1% |
| Q3 FY2017 | Sep 30, 2017 | $245.09M | – |
| Q2 FY2017 | Jun 30, 2017 | $249.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $211.91M | – |
| Q4 FY2016 | Dec 31, 2016 | $170.73M | – |
See a number that looks wrong?